Erez Raphael - 06 Mar 2024 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role: Chief Executive Officer, Director
Signature: /s/ Erez Raphael
Issuer symbol: DRIO
Transactions as of: 06 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 08 Mar 2024, 16:19:38 UTC
Previous filing: 08 May 2023
Next filing: 20 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DRIO	Common Stock	Award	$0	+800,000	+72%	$0.000000	1,912,059	06 Mar 2024	Direct	F1
holding	DRIO	Common Stock						37,876	06 Mar 2024	By Dicilyon Consulting and Investment Ltd.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period.
F2	The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.

Content

The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period.

The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.